UCL News


Trial shows signs new Alzheimer's drug could benefit early-stage patients

1 September 2016

Professor John Hardy (UCL Institute of Neurology) comments on the trial of a new Alzheimer's drug showing promising signs it could slow the early progression of the disease. Read: The Guardian, More: BBC News, International Business Times, Toronto Star, Daily Mail, ITV News, Mirror